Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — Q4 FY2024 Earnings Presentation
24 slides from Gpt Healthcare's earnings presentation, May 21, 2024
Slide 1: Submission of Investors Presentation cover letter
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2024-25 May 21, 2024 The Department of Corporate Services National
Slide 2: Investor Presentation – Q4 & FY24
GPT Healthcare Limited I n v est or P r esen ta t i on – Q 4 & F Y 24 N S E : G P T H E A LT H | B S E : 5 4 4 1 3 1
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Table of Content
Table of Content Company Overview Business Highlights Financial Performance 3
Slide 5: Key regional corporate healthcare companies in Eastern India
GPT Healthcare – Key regional corporate healthcare companies in Eastern India Strategically located in Densely Populated Micro Markets of Kolkata and Howrah, and Agartala Established Right-Sized, Full-Service Hospitals according to each sub-region, aids High Return on Capital 561 90 560 4 Capabi
Slide 6: Salt Lake Hospital (Year 2000)
Salt Lake Hospital (Year 2000) Total 85 Beds, including 17 Beds across ICUs and HDUs along with 3 OTs The Department of Minimal Access Surgery is accredited by National Board of Examinations for training of post-graduate surgeons under the Fellowship of National Board in Minimal Access Surgery Award
Slide 7: Agartala Hospital (Year 2011)
Agartala Hospital (Year 2011) Total 205 Beds, including 66 Beds across ICUs along with 8 OTs & 1 catheterization laboratory The only NABH accredited hospital in Agartala and one among 11 valid accredited hospitals in North-East India as of October 2023. Also accredited by NABL Received the ‘Excellen
Slide 8: Dum Dum Hospital (Year 2013)
Dum Dum Hospital (Year 2013) Total 155 Beds, including 53 Beds across ICUs and HDUs along with 4 OTs & 1 catheterization laboratory NABH accredited and NABL accredited for complying with ISO 15189:2012 standards in the field of medical testing Recognized by the CII for Excellence in Nursing for thei
Slide 9: Howrah Hospital (Year 2019)
Howrah Hospital (Year 2019) Total 116 Beds, including 43 Beds across ICUs and HDUs along with 3 OTs & 1 catheterization laboratory Located in close proximity to the Howrah railway station and enjoys a strong locational advantage Recognized by the CII for Excellence in Nursing for their efforts, comm
Slide 10: Business Highlights
Business Highlights
Slide 11: Focused on High Return on Capital – Factors that lead to it
Focused on High Return on Capital – Factors that lead to it Strategic Location Disciplined Approach Brand Strength Right Sized, towards Costs demonstrated through of the Hospitals Full Service Payor Mix Being in populous neighbourhoods Operating multispecialty, mid sized Strategic measures towards V
Slide 12: Professional and experienced leadership – Board of Directors
Professional and experienced leadership – Board of Directors Dwarika Prasad Tantia Dr. Om Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Wholetime Director Managing Director Whole-time Director Non - Executive Director Non - Executive Director C C M M M M M • Founding member of
Slide 13: Growth Drivers in Place
Growth Drivers in Place Continued Investment in Infrastructure New Hospital Installed cutting-edge robotic surgical Existing Hospitals technology in Salt Lake Hospital and Setting up hospitals on Asset-light basis performed 300+ robotic surgeries where investment in land and building Set up a
Slide 14: Financial Performance
Zz i. * L4 Financial Performance
Slide 15: Robust Performance Continues in Q4 & FY24
Robust Performance Continues in Q4 & FY24 Revenue from Operations EBITDA & EBIDTA Margin PAT & PAT Margin Rs 13 Cr Q4FY24 Q4FY24 Q4FY24 Rs 99 Cr Rs 25 Cr EBITDA Margin 24.6 % PAT Margin 12.7% 22.1% 23.0% 23.0% 12.2% 11.8% 400 21.8% 337 361 10.6% 8.5% 48 243 42 39 93 FY24 FY24 21 FY24 79 80 55 FY21 F
Slide 16: Financial Highlights (As of FY24)
Financial Highlights (As of FY24) 12% Net Profit: Rs 48 Cr Tax: Rs 20 Cr 5% Salt Lake 16% Rs 65 Cr EBITDA : 23% Rs 93 Cr Depreciation : Rs 18 Cr 4% Agartala Finance Cost: Rs 7 Cr 29% 2% Rs 117 Cr 41% Dum Dum: 20% Medicines and Consumables: Rs 167 Cr 100% Rs 83 Cr Howrah 13% __% Employee Benefit Cost
Slide 17: Key Operating Metrics
Key Operating Metrics No. of Beds & Occupancy Rate (%) Average Length of Stay (ALOS) Average Revenue per Occupied Bed (ARPOB) (in Rs per day) 56.4% 58.9% 58.9% 32,947 48.0% 29,253 29,671 5.56 4.80 24,681 556 556 561 561 4.22 3.95 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 No. of Bed
Slide 18: Hospital wise Performance
Hospital wise Performance Salt Lake Hospital Agartala Hospital Dum Dum Hospital Howrah Hospital Data as of FY24 Total (Year - 2000) (Year - 2011) (Year - 2013) (Year - 2019) Bed Capacity (No. of Beds) 85 205 155 116 561 61.2% 53.0% 77.0% 43.6% 58.9% Bed Occupancy Rate (%) ALOS (in Days) 3.2 3.5 5.2
Slide 19: Quarterly Profit & Loss
Quarterly Profit & Loss Particulars (Rs Cr) Q4FY24 Q4FY23 YoY Q3FY24 QoQ FY24 FY23 YoY Revenue from operations 99.4 96.1 3.43% 96.6 2.9% 400.2 361.0 10.8% Other Income 1.6 2.3 -30.43% 1.2 35.8% 5.3 5.7 -7.1% Total Income 101.0 98.4 2.64% 97.8 3.3% 405.5 366.7 10.6% Cost of materials consumed 20.8 20
Slide 20: Annual Profit & Loss
Annual Profit & Loss Particulars (Rs Cr) FY23 FY24 Revenue from operations 361.0 400.2 Other Income 5.7 5.3 Total Income 366.7 405.5 Cost of materials consumed 75.9 83.0 Employee benefits expense 62.0 68.9 Other expenses 148.8 160.5 EBITDA 80.0 93.1 EBITDA Margin 21.8% 23.0% Depreciation and amortis
Slide 21: Annual Balance Sheet
Annual Balance Sheet Assets (Rs Cr) Mar-23 Mar-24 Liabilities (Rs Cr) Mar-23 Mar-24 PPE 203.7 201.1 Share Capital 79.9 82.1 Other Equity 85.5 136.4 Investments 36.6 45.1 Total Equity 165.4 218.5 Other Non- Current Assets 5.2 19.2 Borrowings 40.3 3.6 Non-Current Assets 245.5 265.4 Lease Liabilities 1
Slide 22: Cash Flow Statement
Cash Flow Statement Particulars (in Cr) Mar-23 Mar-24 Cash Flow from Operating Activities Profit before Tax 56.0 68.0 Operating Profit before Working Capital 74.6 91.9 (Increase)/decrease in Inventories -1.6 0.8 (Increase)/decrease in Trade Receivables -7.7 -5.4 (Increase)/decrease in Payables & oth
Slide 23: Stock Information
Stock Information Share Price Movement Shareholding Pattern (as on Mar-24) 250 25,000 29-Feb-2024 Listing Date 22,500 Public Promoters 19.5% 2nd Interim DII 65.6% Dividend of Re.1 /- 200 20,000 7.8% 17,500 FII 7.1% 150 15,000 Price in Rs 12,500 Volumes (in ‘000) 100 10,000 Promoters FII DII Public 7
Slide 24: Thank You
Thank ou GPT Healthcare Limited Stellar IR Advisors Pvt. Ltd. CIN No.: U70101WB1989PLC047402 Contact No.: 022 62398024 ghl.cosec@gptgroup.co.in Ms. Pooja Sharma pooja.sharma@stellar-ir.com For more details : www.ilshospitals.com Mr. Vishal Mehta vishal@stellar-ir.com